Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Sep;67(3):364–368. doi: 10.1136/jnnp.67.3.364

Different clinical aspects of debrancher deficiency myopathy

S Kiechl 1, U Kohlendorfer 1, C Thaler 1, D Skladal 1, M Jaksch 1, B Obermaier-Kusser 1, J Willeit 1
PMCID: PMC1736538  PMID: 10449560

Abstract

OBJECTIVE—To characterise the main clinical phenotypes of debrancher deficiency myopathy and to increase awareness for this probably underdiagnosed disorder.
METHODS—The diagnosis of debrancher deficiency was established by laboratory tests, EMG, and muscle and liver biopsy.
RESULTS—Four patients with debrancher deficiency myopathy were identified in the Tyrol, a federal state of Austria with half a million inhabitants. Clinical appearance was highly variable. The following phenotypes were differentiated: (1) adult onset distal myopathy; (2) subacute myopathy of the respiratory muscles; (3) severe generalised myopathy; and (4) minimal variant myopathy. Exercise intolerance was uncommon. The clinical course was complicated by advanced liver dysfunction in two patients and by severe cardiomyopathy in one. All had raised creatine kinase concentrations (263 to 810 U/l), myogenic and neurogenic features on EMG, and markedly decreased debrancher enzyme activities in muscle or liver biopsy specimens. The findings were substantiated by a review of 79 previously published cases with neuromuscular debrancher deficiency.
CONCLUSIONS—This study illustrates the heterogeneity of neuromuscular manifestations in debrancher deficiency. Based on the clinical appearance, age at onset, and course of disease four phenotypes may be defined which differ in prognosis, frequency of complications, and response to therapy.



Full Text

The Full Text of this article is available as a PDF (102.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brunberg J. A., McCormick W. F., Schochet S. S. Type 3 glycogenosis. An adult with diffuse weakness and muscle wasting. Arch Neurol. 1971 Aug;25(2):171–178. doi: 10.1001/archneur.1971.00490020089011. [DOI] [PubMed] [Google Scholar]
  2. Bröker H. J., Kuhn E., Fiehn W., Assmus H., Schröder J. M. Glykogenose durch Amylo-1,6-glucosidase-Mangel. Myopathie als Leitbefund im Erwachsenenalter. Schweiz Med Wochenschr. 1981 Jun 6;111(23):854–858. [PubMed] [Google Scholar]
  3. Carvalho J. S., Matthews E. E., Leonard J. V., Deanfield J. Cardiomyopathy of glycogen storage disease type III. Heart Vessels. 1993;8(3):155–159. doi: 10.1007/BF01744800. [DOI] [PubMed] [Google Scholar]
  4. Chalmers R. M., Howard R. S., Wiles C. M., Hirsch N. P., Miller D. H., Williams A., Spencer G. T. Respiratory insufficiency in neuronopathic and neuropathic disorders. QJM. 1996 Jun;89(6):469–476. doi: 10.1093/qjmed/89.6.469. [DOI] [PubMed] [Google Scholar]
  5. Chen Y. T., He J. K., Ding J. H., Brown B. I. Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease. Am J Hum Genet. 1987 Dec;41(6):1002–1015. [PMC free article] [PubMed] [Google Scholar]
  6. Cohen R., Lipper S., Dantzker D. R. Inclusion body myositis as a cause of respiratory failure. Chest. 1993 Sep;104(3):975–977. doi: 10.1378/chest.104.3.975. [DOI] [PubMed] [Google Scholar]
  7. Cohn J., Wang P., Hauge M., Henningsen K., Jensen B., Svejgaard A. Amylo-1,60glucosidase deficiency (glycogenosis type III) in the Faroe Islands. Hum Hered. 1975;25(2):115–126. doi: 10.1159/000152716. [DOI] [PubMed] [Google Scholar]
  8. Coleman R. A., Winter H. S., Wolf B., Gilchrist J. M., Chen Y. T. Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med. 1992 Jun 1;116(11):896–900. doi: 10.7326/0003-4819-116-11-896. [DOI] [PubMed] [Google Scholar]
  9. Cornelio F., Bresolin N., Singer P. A., DiMauro S., Rowland L. P. Clinical varieties of neuromuscular disease in debrancher deficiency. Arch Neurol. 1984 Oct;41(10):1027–1032. doi: 10.1001/archneur.1984.04050210025008. [DOI] [PubMed] [Google Scholar]
  10. Dewberry R. G., Schneider B. F., Cale W. F., Phillips L. H., 2nd Sarcoid myopathy presenting with diaphragm weakness. Muscle Nerve. 1993 Aug;16(8):832–835. doi: 10.1002/mus.880160805. [DOI] [PubMed] [Google Scholar]
  11. DiMauro S., Hartwig G. B., Hays A., Eastwood A. B., Franco R., Olarte M., Chang M., Roses A. D., Fetell M., Schoenfeldt R. S. Debrancher deficiency: neuromuscular disorder in 5 adults. Ann Neurol. 1979 May;5(5):422–436. doi: 10.1002/ana.410050504. [DOI] [PubMed] [Google Scholar]
  12. FORBES G. B. Glycogen storage disease; report of a case with abnormal glycogen structure in liver and skeletal muscle. J Pediatr. 1953 Jun;42(6):645–653. doi: 10.1016/s0022-3476(53)80420-8. [DOI] [PubMed] [Google Scholar]
  13. Haagsma E. B., Smit G. P., Niezen-Koning K. E., Gouw A. S., Meerman L., Slooff M. J. Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology. 1997 Mar;25(3):537–540. doi: 10.1002/hep.510250307. [DOI] [PubMed] [Google Scholar]
  14. Hers H. G., Verhue W., Van hoof F. The determination of amylo-1,6-glucosidase. Eur J Biochem. 1967 Oct;2(3):257–264. doi: 10.1111/j.1432-1033.1967.tb00133.x. [DOI] [PubMed] [Google Scholar]
  15. Hokezu Y., Nagamatsu K., Nakagawa M., Osame M., Ohnishi A. [Glycogenosis type III with peripheral nerve disorder and muscular hypertrophy in an adult]. Rinsho Shinkeigaku. 1983 Jun;23(6):473–479. [PubMed] [Google Scholar]
  16. ILLINGWORTH B., CORI G. T., CORI C. F. Amylo-1, 6-glucosidase in muscle tissue in generalized glycogen storage disease. J Biol Chem. 1956 Jan;218(1):123–129. [PubMed] [Google Scholar]
  17. Maire I., Baussan C., Moatti N., Mathieu M., Lemonnier A. Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem. 1991 Apr;24(2):169–178. doi: 10.1016/0009-9120(91)90511-c. [DOI] [PubMed] [Google Scholar]
  18. Marbini A., Gemignani F., Saccardi F., Rimoldi M. Debrancher deficiency neuromuscular disorder with pseudohypertrophy in two brothers. J Neurol. 1989 Oct;236(7):418–420. doi: 10.1007/BF00314902. [DOI] [PubMed] [Google Scholar]
  19. Mineo I., Kono N., Hara N., Shimizu T., Yamada Y., Kawachi M., Kiyokawa H., Wang Y. L., Tarui S. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII. N Engl J Med. 1987 Jul 9;317(2):75–80. doi: 10.1056/NEJM198707093170203. [DOI] [PubMed] [Google Scholar]
  20. Momoi T., Sano H., Yamanaka C., Sasaki H., Mikawa H. Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am J Med Genet. 1992 Mar 1;42(5):696–699. doi: 10.1002/ajmg.1320420514. [DOI] [PubMed] [Google Scholar]
  21. Moses S. W., Gadoth N., Bashan N., Ben-David E., Slonim A., Wanderman K. L. Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand. 1986 Mar;75(2):289–296. doi: 10.1111/j.1651-2227.1986.tb10201.x. [DOI] [PubMed] [Google Scholar]
  22. Murase T., Ikeda H., Muro T., Nakao K., Sugita H. Myopathy associated with type 3 glycogenosis. J Neurol Sci. 1973 Nov;20(3):287–295. doi: 10.1016/0022-510x(73)90190-1. [DOI] [PubMed] [Google Scholar]
  23. Okubo M., Horinishi A., Nakamura N., Aoyama Y., Hashimoto M., Endo Y., Murase T. A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12-->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet. 1998 Jan;102(1):1–5. doi: 10.1007/s004390050646. [DOI] [PubMed] [Google Scholar]
  24. Ozand P., Tokatli M., Amiri S. Biochemical investigation of an unusual case of glycogenosis. J Pediatr. 1967 Aug;71(2):225–232. doi: 10.1016/s0022-3476(67)80077-5. [DOI] [PubMed] [Google Scholar]
  25. Parvari R., Shen J., Hershkovitz E., Chen Y. T., Moses S. W. Two new mutations in the 3' coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient. J Inherit Metab Dis. 1998 Apr;21(2):141–148. doi: 10.1023/a:1005343625756. [DOI] [PubMed] [Google Scholar]
  26. Pellissier J. F., de Barsy T., Faugere M. C., Rebuffel P. Type III glycogenosis with multicore structures. Muscle Nerve. 1979 Mar-Apr;2(2):124–132. doi: 10.1002/mus.880020207. [DOI] [PubMed] [Google Scholar]
  27. Powell H. C., Haas R., Hall C. L., Wolff J. A., Nyhan W., Brown B. I. Peripheral nerve in type III glycogenosis: selective involvement of unmyelinated fiber Schwann cells. Muscle Nerve. 1985 Oct;8(8):667–671. doi: 10.1002/mus.880080808. [DOI] [PubMed] [Google Scholar]
  28. Rosenow E. C., 3rd, Engel A. G. Acid maltase deficiency in adults presenting as respiratory failure. Am J Med. 1978 Mar;64(3):485–491. doi: 10.1016/0002-9343(78)90235-8. [DOI] [PubMed] [Google Scholar]
  29. Rossignol A. M., Meyer M., Rossignol B., Palcoux M. P., Raynaud E. J., Bost M. La myocardiopathie de la glycogénose type III. Arch Fr Pediatr. 1979 Mar;36(3):303–309. [PubMed] [Google Scholar]
  30. Shen J., Bao Y., Liu H. M., Lee P., Leonard J. V., Chen Y. T. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest. 1996 Jul 15;98(2):352–357. doi: 10.1172/JCI118799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Slonim A. E., Coleman R. A., Moses W. S. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr. 1984 Dec;105(6):906–911. doi: 10.1016/s0022-3476(84)80075-x. [DOI] [PubMed] [Google Scholar]
  32. Slonim A. E., Weisberg C., Benke P., Evans O. B., Burr I. M. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol. 1982 Apr;11(4):420–422. doi: 10.1002/ana.410110417. [DOI] [PubMed] [Google Scholar]
  33. Smit G. P., Fernandes J., Leonard J. V., Matthews E. E., Moses S. W., Odievre M., Ullrich K. The long-term outcome of patients with glycogen storage diseases. J Inherit Metab Dis. 1990;13(4):411–418. doi: 10.1007/BF01799498. [DOI] [PubMed] [Google Scholar]
  34. Talente G. M., Coleman R. A., Alter C., Baker L., Brown B. I., Cannon R. A., Chen Y. T., Crigler J. F., Jr, Ferreira P., Haworth J. C. Glycogen storage disease in adults. Ann Intern Med. 1994 Feb 1;120(3):218–226. doi: 10.7326/0003-4819-120-3-199402010-00008. [DOI] [PubMed] [Google Scholar]
  35. Ugawa Y., Inoue K., Takemura T., Iwamasa T. Accumulation of glycogen in sural nerve axons in adult-onset type III glycogenosis. Ann Neurol. 1986 Mar;19(3):294–297. doi: 10.1002/ana.410190313. [DOI] [PubMed] [Google Scholar]
  36. Van Hoof F. Amylo-1,6-glucosidase activity and glycogen content of the erythrocytes of normal subjects, patients with glycogen storage disease and heterozygotes. Eur J Biochem. 1967 Oct;2(3):271–274. doi: 10.1111/j.1432-1033.1967.tb00135.x. [DOI] [PubMed] [Google Scholar]
  37. Van Hoof F., Hers H. G. The subgroups of type 3 glycogenosis. Eur J Biochem. 1967 Oct;2(3):265–270. doi: 10.1111/j.1432-1033.1967.tb00134.x. [DOI] [PubMed] [Google Scholar]
  38. Yang B. Z., Stewart C., Ding J. H., Chen Y. T. Type III glycogen storage disease: an adult case with mild disease but complete absence of debrancher protein. Neuromuscul Disord. 1991;1(3):173–176. doi: 10.1016/0960-8966(91)90021-j. [DOI] [PubMed] [Google Scholar]
  39. de Carvalho M., Matias T., Coelho F., Evangelista T., Pinto A., Luís M. L. Motor neuron disease presenting with respiratory failure. J Neurol Sci. 1996 Aug;139 (Suppl):117–122. doi: 10.1016/0022-510x(96)00089-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES